受影响的尖峰频率适应与KCNQ2/3的减少相关,加剧了叶发作中的发作活动
Shicheng Jiang1,2, Bei Liu3, Kaiwen Lin1,2
1Department of Pathophysiology, Bengbu Medical College, Bengbu, Anhui, China.
Hippocampus
|December 5, 2023
概括
下调的KCNQ2/3通道基因与叶 (TLE) 发作发作有关. 在TLE中受损的M电流有助于长时间的发作,这表明KCNQ2/3是潜在的抗药物标.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 的研究研究.
背景情况:
- 对于叶 (TLE) 存在有限的可用药物标.
- 许多相关基因需要进一步验证治疗潜力.
研究的目的:
- 研究KCNQ2和KCNQ3基因在TLE发作发作中的作用.
- 确定KCNQ2/3作为TLE的潜在治疗点.
主要方法:
- 对TLE患者数据库的定量分析.
- 在皮洛卡尔平发作小鼠模型中复制发现.
- 状状网络模拟,以评估M电流功能.
主要成果:
- 下调的KCNQ2/3表达与TLE发作发生相关.
- 牙状状粒细胞神经元中受损的M电流降低了尖峰频率适应.
- 模拟证实适应障碍促进了型活动,延长了发作.
结论:
- 基因KCNQ2/3在TLE的生殖过程中起着重要作用.
- 损坏的M电流有助于发作的持续时间和TLE中缩短的间歇间隔.
- KCNQ2/3代表了开发新型抗药物的有希望的目标.
关键词:
KCNQ 2/3, 2/3, 2/3, 2/3, 3/4, KCNQ 2/3, KCNQ 2/3, KCNQ 2/3, KCNQ 3/4, KCNQ 2/3, KCNQ 3/4, KCNQ 2/3, KCNQ 3/4, KCNQ 2/3, KCNQ 3/4, KCNQ 2/3, KCNQ 3/4, KCNQ 3/4, KCNQ 4/3, KCNQ 5/3, KCNQ 5/3, KCNQ 6/3, KCNQ 6/3, KCNQ 6/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/3, KCNQ 7/4, KCNQ 7/3, KCNQ 7/3, KCNQ 7/4, KCNQ 7在M电流下,电流为M.有牙的吉鲁斯.颗粒细胞颗粒细胞的细胞.峰值频率适应的调整在叶发作.相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
376
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
376
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Arteries of the Lower Limbs
192
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
192
Antiepileptic Drugs: Calcium Channel Blockers
414
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
414
Antiepileptic Drugs: Sodium Channel Blockers
592
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
592
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K


